| Mycobacterium research and diagnosis | Lifetime | 16 | US 8 | 99.81 |
| Tuberculosis Research and Epidemiology | Lifetime | 43 | US 20 | 99.72 |
| Infectious Diseases and Mycology | Lifetime | 18 | US 8 | 99.67 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 50 | US 16 | 99.72 |
| Infectious Diseases and Tuberculosis | Lifetime | 45 | US 15 | 99.38 |
| Systemic Lupus Erythematosus Research | Lifetime | 92 | US 37 | 99.57 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 44 | US 15 | 99.55 |
| Quinazolinone synthesis and applications | Lifetime | 31 | US 7 | 98.56 |
| Herpesvirus Infections and Treatments | Lifetime | 138 | US 94 | 98.93 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 336 | US 158 | 98.43 |
| Biosimilars and Bioanalytical Methods | Lifetime | 106 | US 39 | 97.82 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 804 | US 374 | 98.04 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 751 | US 333 | 96.40 |
| Cystic Fibrosis Research Advances | Lifetime | 608 | US 248 | 95.65 |
| Spondyloarthritis Studies and Treatments | Lifetime | 732 | US 126 | 93.46 |
| Mycobacterium research and diagnosis | 2021-2025 | 1 | US 1 | 99.60 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 10 | US 2 | 99.74 |
| Herpesvirus Infections and Treatments | 2021-2025 | 14 | US 9 | 98.42 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 30 | US 10 | 99.13 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 19 | US 6 | 99.36 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 35 | US 7 | 98.95 |
| Infectious Diseases and Mycology | 2021-2025 | 6 | US 3 | 98.08 |
| Quinazolinone synthesis and applications | 2021-2025 | 33 | US 4 | 93.39 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 106 | US 39 | 94.01 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 473 | US 209 | 95.24 |
| Tracheal and airway disorders | 2021-2025 | 417 | US 152 | 92.29 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 199 | US 30 | 94.19 |
| Cystic Fibrosis Research Advances | 2021-2025 | 337 | US 119 | 92.19 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 516 | US 138 | 88.90 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 286 | US 59 | 82.09 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 923 | US 150 | 82.48 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 973 | US 371 | 76.56 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 433 | US 92 | 72.89 |
| Intramuscular injections and effects | 2021-2025 | 97 | US 18 | 71.34 |
| Microwave-Assisted Synthesis and Applications | 2021-2025 | 689 | US 33 | 17.76 |
